Literature DB >> 36187521

Serum MicroRNA 21 and Tumour Marker in Oesophagus Cancer: Correspondence.

Rujittika Mungmunpuntipantip1, Viroj Wiwanitkit2.   

Abstract

Entities:  

Year:  2022        PMID: 36187521      PMCID: PMC9515279          DOI: 10.1007/s13193-022-01536-4

Source DB:  PubMed          Journal:  Indian J Surg Oncol        ISSN: 0975-7651


× No keyword cloud information.
  5 in total

1.  Circulating miRNAs as novel potential biomarkers for esophageal squamous cell carcinoma diagnosis: a meta-analysis update.

Authors:  Fen Liu; Tian Tian; Li-Li Xia; Yuanjie Ding; Robert T Cormier; Yan He
Journal:  Dis Esophagus       Date:  2017-02-01       Impact factor: 3.429

Review 2.  MicroRNA targets and biomarker validation for diabetes-associated cardiac fibrosis.

Authors:  Zhu-Qiu Jin
Journal:  Pharmacol Res       Date:  2021-10-14       Impact factor: 7.658

3.  Estimation of Serum MicroRNA 21 as a Tumour Marker in Carcinoma Oesophagus.

Authors:  Sruthy Harshan; Lancelot Lobo; Suchetha Kumari; Shilpa Shetty
Journal:  Indian J Surg Oncol       Date:  2021-07-08

4.  Serum miR-331-3p predicts tumor recurrence in esophageal adenocarcinoma.

Authors:  Jianchun Gu; Jinhua Zhang; Leizhen Zheng; Jaffer A Ajani; Xifeng Wu; Yuanqing Ye
Journal:  Sci Rep       Date:  2018-09-18       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.